Cambridge Investment Research Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $425K | Buy |
43,897
+752
| +2% | +$7.28K | ﹤0.01% | 2684 |
|
2025
Q1 | $642K | Buy |
43,145
+243
| +0.6% | +$3.62K | ﹤0.01% | 2209 |
|
2024
Q4 | $640K | Sell |
42,902
-8,767
| -17% | -$131K | ﹤0.01% | 2227 |
|
2024
Q3 | $988K | Buy |
51,669
+1,705
| +3% | +$32.6K | ﹤0.01% | 1862 |
|
2024
Q2 | $1.03M | Buy |
49,964
+11,254
| +29% | +$233K | ﹤0.01% | 1750 |
|
2024
Q1 | $728K | Buy |
38,710
+18,733
| +94% | +$352K | ﹤0.01% | 1962 |
|
2023
Q4 | $288K | Sell |
19,977
-4,182
| -17% | -$60.3K | ﹤0.01% | 2624 |
|
2023
Q3 | $419K | Buy |
24,159
+1,838
| +8% | +$31.9K | ﹤0.01% | 2233 |
|
2023
Q2 | $465K | Sell |
22,321
-5,767
| -21% | -$120K | ﹤0.01% | 2195 |
|
2023
Q1 | $661K | Sell |
28,088
-326
| -1% | -$7.67K | ﹤0.01% | 1892 |
|
2022
Q4 | $794K | Sell |
28,414
-3,526
| -11% | -$98.5K | ﹤0.01% | 1668 |
|
2022
Q3 | $747K | Buy |
31,940
+155
| +0.5% | +$3.63K | ﹤0.01% | 1673 |
|
2022
Q2 | $1.07M | Sell |
31,785
-609
| -2% | -$20.6K | 0.01% | 1430 |
|
2022
Q1 | $1.13M | Sell |
32,394
-2,003
| -6% | -$70K | 0.01% | 1485 |
|
2021
Q4 | $1.05M | Sell |
34,397
-6,320
| -16% | -$192K | ﹤0.01% | 1552 |
|
2021
Q3 | $1.34M | Buy |
40,717
+2,219
| +6% | +$72.8K | 0.01% | 1327 |
|
2021
Q2 | $1.17M | Buy |
+38,498
| New | +$1.17M | 0.01% | 1423 |
|